Target intelligence / Profile preview

Phosphatase and tensin homolog pseudogene (PTENP1)

Target
PTENP1
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

The phosphatase and tensin homolog pseudogene (commonly referred to as PTENP1) is a non-protein-coding RNA gene related to the canonical PTEN tumor suppressor gene. While PTENP1 shares high sequence similarity with PTEN, it does not produce a functional phosphatase enzyme. PTENP1 and other PTEN pseudogenes can act post-transcriptionally to regulate the expression and stability of PTEN mRNA by serving as competing endogenous RNAs, thus indirectly influencing PTEN protein levels and thereby tumor biology. However, PTENP1 itself is not an established therapeutic target because it does not encode a protein product[2]. Only the canonical PTEN (phosphatase and tensin homolog) exhibits enzymatic activity with critical roles in *PI3K/AKT/mTOR signaling*, *cell proliferation*, *growth*, and *tumor suppression*[1][2][3][4][5]. Important note: The canonical target in most research and clinical contexts is Phosphatase and tensin homolog (PTEN), not the pseudogene. PTEN is a therapeutic target, tumor suppressor, and lipid/protein phosphatase involved in cell signaling, metabolism, and cancer[1][2][3][4][5]. The pseudogene (ENSG00000261882, PTENP1) is not directly targeted for therapy and does not produce an active protein[2]. There appears to be a nomenclature error or copy-paste mistake in the query as written (repetition of "phosphatase and tensin homolog" and ambiguous reference to a pseudogene).

Other names
PTENP1phosphatase and tensin homolog pseudogene 1PTEN pseudogene
02

Biological functions

Regulation of PTEN expression via RNA interactionsModulation of PTEN mRNA stability and translation (competitive endogenous RNA)Involvement in regulatory non-coding RNA networks
03

Disease associations

Cancer (indirectly via PTEN regulation)

Beyond the preview

Go deeper on Phosphatase and tensin homolog pseudogene (PTENP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatase and tensin homolog pseudogene (PTENP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call